{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:17:31Z","timestamp":1792196251743,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4175,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1538-7836.2011.04302.x","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T06:09:56Z","timestamp":1311919796000},"page":"344-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"S1","title":["Stroke in atrial fibrillation: epidemiology and thromboprophylaxis"],"prefix":"10.1016","volume":"9","author":[{"given":"G.Y.H.","family":"LIP","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1474-4422(07)70264-8","article-title":"Atrial fibrillation and stroke prevention","volume":"6","author":"Lip","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1160\/TH10-01-0038","article-title":"Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at \u2018moderate risk\u2019 [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real\u2010life clinical practice","volume":"103","author":"Lip","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1160\/TH09-05-0327","article-title":"New oral anticoagulant drugs in cardiovascular disease","volume":"104","author":"Ahrens","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0025","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta9400","article-title":"A randomised controlled trial and cost\u2010effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study","volume":"9","author":"Hobbs","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0030","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0040","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0045","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.STR.27.10.1765","article-title":"Acute stroke with atrial fibrillation. The Copenhagen Stroke Study","volume":"27","author":"J\u00f8rgensen","year":"1996","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0050","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","article-title":"Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population based study","volume":"36","author":"Marini","year":"2005","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0055","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ehj.2004.06.030","article-title":"Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry","volume":"25","author":"Steger","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/hrt.2002.008748","article-title":"Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK","volume":"90","author":"Stewart","year":"2004","journal-title":"Heart"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0002-8703(03)00524-6","article-title":"Cost of care distribution in atrial fibrillation patients: the COCAF study","volume":"147","author":"Le Heuzey","year":"2004","journal-title":"Am Heart J"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","article-title":"Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia","volume":"89","author":"Page","year":"1994","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0075","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.105.568568","article-title":"New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features","volume":"113","author":"Hoffmann","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0080","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ehj.2004.04.015","article-title":"Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial","volume":"25","author":"Fetsch","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0085","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/STROKEAHA.106.478685","article-title":"Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review","volume":"38","author":"Liao","year":"2007","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0090","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/01.STR.0000131269.69502.d9","article-title":"Usefulness of ambulatory 7\u2010day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack","volume":"35","author":"Jabaudon","year":"2004","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0095","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","article-title":"Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers","volume":"46","author":"Capucci","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","article-title":"Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events","volume":"20","author":"Botto","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0105","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.110.609297","article-title":"Improving stroke risk stratification using the CHADS2 and CHA2DS2\u2010VASc risk scores in paroxysmal atrial fibrillation patients by continuous arrhythmia burden monitoring","author":"Boriani","year":"2011","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0110","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","article-title":"Independent predictors of stroke in patients with atrial fibrillation: a systematic review","volume":"69","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH07-08-0508","article-title":"Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data","volume":"99","author":"Hughes","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0120","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1160\/TH09-10-0746","article-title":"Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1","volume":"103","author":"Gorin","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0125","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0130","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1160\/TH09-11-0757","article-title":"The CHADS2 score for stroke risk stratification in atrial fibrillation \u2013 friend or foe?","volume":"104","author":"Karthikeyan","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor\u2010based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1538-7836.2010.04085.x","article-title":"A comparison of risk stratification schema for stroke in 79884 atrial fibrillation patients in general practice","volume":"9","author":"van Staa","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: a nationwide cohort study","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0155","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/STROKEAHA.110.590257","article-title":"Identifying patients at high risk for stroke despite anticoagulation. a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort","volume":"41","author":"Lip","year":"2010","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1540-8167.2010.01858.x","article-title":"Stroke risk stratification in a \u201cReal\u2010World\u201d elderly anticoagulated atrial fibrillation population","volume":"22","author":"Poli","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0165","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/qjmed\/hcm076","article-title":"Risk factors for anticoagulation\u2010related bleeding complications in patients with atrial fibrillation: a systematic review","volume":"100","author":"Hughes","year":"2007","journal-title":"QJM"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1160\/TH08-11-0730","article-title":"Bleeding with anticoagulation therapy \u2010 who is at risk, and how best to identify such patients","volume":"102","author":"Palareti","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0175","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/europace\/eur126","article-title":"Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis","volume":"13","author":"Lip","year":"2011","journal-title":"Europace"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0180","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user\u2010friendly score (has\u2010bled) to assess one\u2010year risk of major bleeding in atrial fibrillation patients: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0190","first-page":"74","article-title":"Canadian cardiovascular society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter","volume":"27","author":"Cairns","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0195","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.0000230607.07928.17","article-title":"Atrial fibrillation and stroke in the general medicare population: a 10\u2010year perspective (1992 to 2002)","volume":"37","author":"Lakshminarayan","year":"2006","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1160\/TH08-08-0499","article-title":"How effective are dose\u2010adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database","volume":"101","author":"Reitbrock","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta\u2010analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0215","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0220","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1160\/TH10-10-0642","article-title":"Treatments for stroke prevention in atrial fibrillation: a network meta\u2010analysis and indirect comparisons versus dabigatran etexilate","volume":"104","author":"Roskell","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1052-3057(10)80159-4","article-title":"A differential effect of aspirin in prevention of stroke on atrial fibrillation","volume":"3","year":"1993","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0230","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/STROKEAHA.108.526988","article-title":"Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators","volume":"40","author":"van Walraven","year":"2009","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA). A randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ageing\/afl129","article-title":"A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)","volume":"36","author":"Rash","year":"2007","journal-title":"Age Ageing"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0245","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.STR.0000198839.61112.ee","article-title":"Low\u2010dose aspirin for prevention of stroke in low\u2010risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial","volume":"37","author":"Sato","year":"2006","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjmed.2010.05.007","article-title":"Implications of the CHA(2)DS(2)\u2010VASc and HAS\u2010BLED scores for thromboprophylaxis in atrial fibrillation","volume":"124","author":"Lip","year":"2011","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0260","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1160\/TH10-07-0491","article-title":"New\u2010onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs","volume":"104","author":"Garcia","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0265","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1160\/TH08-06-0388","article-title":"Cardiovascular risk factors in patients at high risk of atherothrombosis: what can be learned from registries?","volume":"100","author":"Goto","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0270","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1160\/TH09-02-0106","article-title":"Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients","volume":"101","author":"Lane","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0275","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1160\/TH10-05-0332","article-title":"Atherothrombosis and atrial fibrillation: Important and often overlapping clinical syndromes","volume":"104","author":"Depta","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0280","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000236840.00467.84","article-title":"Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation","volume":"37","author":"Lip","year":"2006","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0285","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jacc.2009.12.049","article-title":"Evidence that D\u2010dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy","volume":"55","author":"Sadanaga","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0290","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/01.STR.0000260090.90508.3e","article-title":"High\u2010sensitivity C\u2010reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis","volume":"38","author":"Lip","year":"2007","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/europace\/euq427","article-title":"Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk","volume":"13","author":"Lip","year":"2011","journal-title":"Europace"},{"key":"10.1111\/j.1538-7836.2011.04302.x_bb0300","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2010.12.013","article-title":"Severe renal impairment and stroke prevention in atrial fibrillation implications for thromboprophylaxis and bleeding risk","volume":"57","author":"Marinigh","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2011.04302.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622055143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622055143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2011.04302.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:59:44Z","timestamp":1761533984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622055143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":59,"alternative-id":["S1538783622055143"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04302.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stroke in atrial fibrillation: epidemiology and thromboprophylaxis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04302.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}